ADAR1 Capital Management, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$652.1M
Holdings
203
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (203 positions)
| Stock | Value |
|---|---|
KROSKEROS THERAPEUTICS INC | $71.9M |
PTGXPROTAGONIST THERAPEUTICS INC | $52.4M |
SPYSPDR S&P 500 ETF TR | $39.0M |
BOXXEA SERIES TRUST | $38.0M |
ZLABZAI LAB LTD | $29.7M |
ABVXABIVAX SA | $23.5M |
ROIVROIVANT SCIENCES LTD | $21.9M |
PRTAPROTHENA CORP PLC | $20.5M |
CYTKCYTOKINETICS INC | $19.2M |
CGONCG ONCOLOGY INC | $13.6M |
BILSPDR SERIES TRUST | $12.4M |
BBIOBRIDGEBIO PHARMA INC | $11.2M |
IKTINHIBIKASE THERAPEUTICS INC | $10.0M |
SEPNSEPTERNA INC | $9.0M |
I9DNARBUTUS BIOPHARMA CORP | $8.7M |
ETNBGBP89BIO INC | $8.6M |
IMVTIMMUNOVANT INC | $8.6M |
YB4PSAVARA INC | $8.2M |
XENEXENON PHARMACEUTICALS INC | $8.1M |
BIOABIOAGE LABS INC | $8.0M |
—PERCEPTIVE CAP SOLUTIONS COR | $8.0M |
AMLXAMYLYX PHARMACEUTICALS INC | $7.7M |
JANXJANUX THERAPEUTICS INC | $7.6M |
CTMXCYTOMX THERAPEUTICS INC | $7.0M |
TSHATAYSHA GENE THERAPIES INC | $7.0M |
SG7SAGE THERAPEUTICS INC | $6.6M |
RAPTRAPT THERAPEUTICS INC | $6.3M |
YCYAA MISSION ACQUISITION CORP | $6.0M |
ISIIONIS PHARMACEUTICALS INC | $5.9M |
TEVATEVA PHARMACEUTICAL INDS LTD | $5.8M |
OACCOAKTREE ACQUISITION CORP III | $5.5M |
VERVVERVE THERAPEUTICS INC | $5.3M |
RVMDREVOLUTION MEDICINES INC | $4.9M |
HLXCHELIX ACQUISITION CORP II | $4.7M |
SRPTSAREPTA THERAPEUTICS INC | $4.5M |
SHYISHARES TR | $4.4M |
RZLTREZOLUTE INC | $4.4M |
BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | $4.2M |
MLYSMINERALYS THERAPEUTICS INC | $4.1M |
CNTACENTESSA PHARMACEUTICALS PLC | $3.9M |
MNPRMONOPAR THERAPEUTICS INC | $3.6M |
ARDXARDELYX INC | $3.6M |
THRDTHIRD HARMONIC BIO INC | $3.4M |
PCVXVAXCYTE INC | $3.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $2.9M |
VRNAVERONA PHARMA PLC | $2.7M |
BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | $2.5M |
ALECALECTOR INC | $2.4M |
VRDNVIRIDIAN THERAPEUTICS INC | $2.4M |
SMMTSUMMIT THERAPEUTICS INC | $2.4M |
ASPCRA SPAC III ACQUISITION CORP | $2.2M |
CRMDCORMEDIX INC | $2.2M |
NAMSNEWAMSTERDAM PHARMA COMPANY | $2.0M |
DCTHDELCATH SYS INC | $2.0M |
AVRANTERIS TECHNOLOGIES GLOBAL | $2.0M |
2L9BLUEPRINT MEDICINES CORP | $1.9M |
VKTXVIKING THERAPEUTICS INC | $1.8M |
AKROAKERO THERAPEUTICS INC | $1.8M |
REGNREGENERON PHARMACEUTICALS | $1.8M |
RGNXREGENXBIO INC | $1.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $1.7M |
MLTXMOONLAKE IMMUNOTHERAPEUTICS | $1.6M |
ORKAORUKA THERAPEUTICS INC | $1.6M |
KNSAKINIKSA PHARMACEUTICALS INTL | $1.6M |
CRNXCRINETICS PHARMACEUTICALS IN | $1.5M |
TECXTECTONIC THERAPEUTIC INC | $1.5M |
SLNOSOLENO THERAPEUTICS INC | $1.5M |
SRRKSCHOLAR ROCK HLDG CORP | $1.4M |
CATBUSDASTRIA THERAPEUTICS INC | $1.3M |
NKTRNEKTAR THERAPEUTICS | $1.3M |
ALKSALKERMES PLC | $1.3M |
VIRVIR BIOTECHNOLOGY INC | $1.3M |
AGIOAGIOS PHARMACEUTICALS INC | $1.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $1.2M |
SWTXSPRINGWORKS THERAPEUTICS INC | $1.1M |
ESTAESTABLISHMENT LABS HLDGS INC | $1.1M |
ABOSACUMEN PHARMACEUTICALS INC | $1.1M |
CDTXCIDARA THERAPEUTICS INC | $1.0M |
ZURAZURA BIO LTD | $1.0M |
BSAABEST SPAC I ACQUISITION CORP | $1.0M |
ARGXARGENX SE | $970K |
MRUSMERUS N V | $963K |
ALDXALDEYRA THERAPEUTICS INC | $957K |
PFEPFIZER INC | $955K |
ARVNARVINAS INC | $948K |
ACLXARCELLX INC | $919K |
NUVLNUVALENT INC | $904K |
TENXTENAX THERAPEUTICS INC | $896K |
SGRYSURGERY PARTNERS INC | $889K |
ARWRARROWHEAD PHARMACEUTICALS IN | $872K |
KRROKORRO BIO INC | $859K |
KVACKEEN VISION ACQUISITION CORP | $853K |
VTGNVISTAGEN THERAPEUTICS INC | $842K |
BHVNBIOHAVEN LTD | $809K |
APGEAPOGEE THERAPEUTICS INC | $785K |
WVEWAVE LIFE SCIENCES LTD | $746K |
KALAKALA BIO INC | $713K |
LRMRLARIMAR THERAPEUTICS INC | $687K |
RCKTROCKET PHARMACEUTICALS INC | $676K |
KZRKEZAR LIFE SCIENCES INC | $675K |
Page 1 of 3Next